Skip to main content
logo
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
87.67
+0.14 (0.15%)
Nov 3, 2026, 1:53 PM EST - Market open

BioNTech SE Financials Overview

Millions EUR. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Revenue
1,289105.6118.1907.41,519260.8182.81,1901,245128.7187.61,479895.3167.71,2774,2783,4613,1976,3755,533
Revenue Growth
-15.12%-59.51%-35.39%-23.75%22.02%102.64%-2.56%-19.54%39.04%-23.26%-85.31%-65.43%-74.13%-94.75%-79.97%-22.67%-43.14%-39.78%211.20%1501.77%
Gross Profit
1,1868.646.7604.61,371184.499946.51,06668.9128.51,300733.54.81,1814,0952,7082,4325,0814,949
Operating Income
125-851.8-681-302.6-33-430.2-535.3158.520.9-961.8-503.11,00652.4-489.2778.53,6591,9381,6934,6294,379
Net Income
184.5-820.8-531.9-305-28.7-386.6-415.8259.5198.1-807.8-315.1457.9160.6-190.4502.22,2791,7851,6723,6993,166
Earnings Per Share
0.73-3.24-2.10-1.25-0.12-1.60-1.731.080.81-3.36-1.311.900.66-0.792.059.266.986.4514.2412.18
EPS Growth
--------43.20%22.73%---79.52%-90.54%--85.60%-23.94%-43.48%-40.11%224.37%880.76%

Revenue by Segment
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23
COVID-19 Vaccine
554.351.966.9855.7853.3153.31331,1221,11471.9124.21,470885158.21,264
Out-Licensing
68300-61300--------
Other Sales
51.953.751.251.752.6107.549.867.9130.956.863.49.510.39.513.5
Other
29.340.230.4025.378.261.600000000
Revenue (Total)
1,319145.8148.5907.41,544339244.41,1901,245128.7187.61,479895.3167.71,277

Cash & Debt
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Cash & Investments
10,20113,46413,70713,74114,36913,63413,72715,84416,70417,29515,66716,54915,74915,55712,50214,06513,4299,3356,1652,074
Total Debt
359.8316.1302.8267.4245.4269.6293254.2243.7254.6236.3219.1201.9205.7209.8212.2274238.9186301.5
Net Cash (Debt)
9,84113,14813,40413,47314,12313,36413,43415,59016,46017,04015,43016,33015,54715,35212,29213,85213,1559,0965,9791,773
Net Cash Growth
-30.32%-1.62%-0.22%-13.58%-14.20%-21.57%-12.94%-4.53%5.87%11.00%25.53%17.88%18.19%68.77%105.59%681.38%524.09%1282.16%838.03%60.10%
Net Cash Per Share
38.9451.9052.9255.2259.0555.3155.8964.8867.3070.8864.1567.7663.8963.7050.1856.2951.4435.0923.026.82

Cash Flow & CapEx
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Operating Cash Flow
-129.810.5-421309.5780.7146.5-780.7-463.3-638.91,627-317.3850.9811.24,387-677.4829.24,7793,9194,050-199.5
Capital Expenditures
-33.6-54.6-56.8-63.2-35.9-27.1-48.9-66.6-72.8-88.6-58.5-83.7-54-67.2-45.2-136.6-77.9-70.6-44.1-39.4
Free Cash Flow
-163.4-44.1-477.8246.3744.8119.4-829.6-529.9-711.71,539-375.8767.2757.24,320-722.6692.64,7013,8494,006-238.9
Free Cash Flow Growth
------92.24%----64.38%-10.77%-83.89%12.24%--221.92%---

Margins
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
Gross Margin
91.99%8.14%39.54%66.63%90.24%70.71%54.16%79.54%85.63%53.53%68.50%87.89%81.93%2.86%92.48%95.71%78.25%76.08%79.70%89.46%
Operating Margin
9.70%-806.63%-576.63%-33.35%-2.17%-164.95%-292.83%13.32%1.68%-747.32%-268.18%67.98%5.85%-291.71%60.96%85.52%56.00%52.95%72.61%79.16%
Pretax Margin
17.22%-813.16%-481.03%-25.06%1.63%-154.41%-243.65%25.31%12.75%-626.11%-176.87%44.84%25.40%-245.80%55.42%74.16%70.61%72.56%78.72%85.20%
Profit Margin
14.31%-777.27%-450.38%-33.61%-1.89%-148.24%-227.46%21.81%15.91%-627.66%-167.96%30.96%17.94%-113.54%39.33%53.26%51.57%52.31%58.02%57.23%
FCF Margin
-12.68%-41.76%-404.57%27.14%49.04%45.78%-453.83%-44.53%-57.17%1195.49%-200.32%51.87%84.58%2575.73%-56.59%16.19%135.82%120.40%62.84%-4.32%

Valuation
Chart
Fiscal Quarter
Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Period EndingSep '26 Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21
PE Ratio
-----------24.408.95-4.433.623.242.952.905.32
Forward PE
100.62100.62100.62100.62100.62100.62100.62100.62100.62100.62100.6267.8130.2431.2317.258.277.756.414.438.07
P/FCF Ratio
---69.41-----6.74-4.434.882.65-2.582.713.827.30-
PS Ratio
8.987.776.596.796.417.767.369.598.336.737.455.943.722.592.261.971.801.641.602.89